Cargando…

Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care

Background: Contaminated healthcare facility plumbing is increasingly recognized as a source of carbapenemase-producing organisms (CPOs). In August 2019, the Tennessee State Public Health Laboratory identified Tennessee’s twelfth VIM-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Allison, Shugart, Alicia, Burks, Albert, Moore, Christina, Gable, Paige, Moulton-Meissner, Heather, McAllister, Gillian, Halpin, Alison, Walters, Maroya, Keaton, Amelia, Tobey, Kelley, Thure, Katie, Schmedes, Sarah, Hardin, Henrietta, Lawsin, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551474/
http://dx.doi.org/10.1017/ash.2021.47
_version_ 1784806108619079680
author Chan, Allison
Shugart, Alicia
Burks, Albert
Moore, Christina
Gable, Paige
Moulton-Meissner, Heather
McAllister, Gillian
Halpin, Alison
Walters, Maroya
Keaton, Amelia
Tobey, Kelley
Thure, Katie
Schmedes, Sarah
Gable, Paige
Hardin, Henrietta
Lawsin, Adrian
author_facet Chan, Allison
Shugart, Alicia
Burks, Albert
Moore, Christina
Gable, Paige
Moulton-Meissner, Heather
McAllister, Gillian
Halpin, Alison
Walters, Maroya
Keaton, Amelia
Tobey, Kelley
Thure, Katie
Schmedes, Sarah
Gable, Paige
Hardin, Henrietta
Lawsin, Adrian
author_sort Chan, Allison
collection PubMed
description Background: Contaminated healthcare facility plumbing is increasingly recognized as a source of carbapenemase-producing organisms (CPOs). In August 2019, the Tennessee State Public Health Laboratory identified Tennessee’s twelfth VIM-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA), from a patient in a long-term acute-care hospital. To determine a potential reservoir, the Tennessee Department of Health (TDH) reviewed healthcare exposures for all cases. Four cases (33%), including the most recent case and earliest from March 2018, had a history of admission to intensive care unit (ICU) room X at acute-care hospital A (ACH A), but the specimens were collected at other facilities. The Public Health Laboratory collaborated with ACH A to assess exposures, perform environmental sampling, and implement control measures. Methods: TDH conducted in-person infection prevention assessments with ACH A, including a review of the water management program. Initial recommendations included placing all patients admitted to room X on contact precautions, screening for CPO on room discharge, daily sink basin and counter cleaning, and other sink hygiene measures. TDH collected environmental and water samples from 5 ICU sinks (ie, the handwashing and bathroom sinks in room X and neighboring room Y [control] and 1 hallway sink) and assessed the presence of VIM-CRPA. Moreover, 5 patients and 4 environmental VIM-CRPA underwent whole-genome sequencing (WGS). Results: From February to June 2020, of 21 patients admitted to room X, 9 (43%) underwent discharge screening and 4 (44%) were colonized with VIM-CRPA. Average room X length of stay was longer for colonized patients (11.3 vs 4.8 days). Drain swabs from room X’s bathroom and handwashing sinks grew VIM-CRPA; VIM-CRPA was not detected in tap water or other swab samples. VIM-CRPA from the environment and patients were sequence type 253 and varied by 0–13 single-nucleotide variants. ACH A replaced room X’s sinks and external plumbing in July. Discharge screening and contact precautions for all patients were discontinued in November, 5 months following the last case and 12 consecutive negative patient discharge screens. Improved sink hygiene and mechanism testing for CRPA from clinical cultures continued, with no new cases identified. Conclusions: An ICU room with a persistently contaminated sink drain was a persistent reservoir of VIM-CRPA. The room X attack rate was high, with VIM-CRPA acquisition occurring in >40% of patients screened. The use of contaminated plumbing fixtures in ACH have the potential to facilitate transmission to patients but may be challenging to identify and remediate. All healthcare facilities should follow sink hygiene best practices. Funding: No Disclosures: None
format Online
Article
Text
id pubmed-9551474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95514742022-10-12 Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care Chan, Allison Shugart, Alicia Burks, Albert Moore, Christina Gable, Paige Moulton-Meissner, Heather McAllister, Gillian Halpin, Alison Walters, Maroya Keaton, Amelia Tobey, Kelley Thure, Katie Schmedes, Sarah Gable, Paige Hardin, Henrietta Lawsin, Adrian Antimicrob Steward Healthc Epidemiol Outbreaks Background: Contaminated healthcare facility plumbing is increasingly recognized as a source of carbapenemase-producing organisms (CPOs). In August 2019, the Tennessee State Public Health Laboratory identified Tennessee’s twelfth VIM-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA), from a patient in a long-term acute-care hospital. To determine a potential reservoir, the Tennessee Department of Health (TDH) reviewed healthcare exposures for all cases. Four cases (33%), including the most recent case and earliest from March 2018, had a history of admission to intensive care unit (ICU) room X at acute-care hospital A (ACH A), but the specimens were collected at other facilities. The Public Health Laboratory collaborated with ACH A to assess exposures, perform environmental sampling, and implement control measures. Methods: TDH conducted in-person infection prevention assessments with ACH A, including a review of the water management program. Initial recommendations included placing all patients admitted to room X on contact precautions, screening for CPO on room discharge, daily sink basin and counter cleaning, and other sink hygiene measures. TDH collected environmental and water samples from 5 ICU sinks (ie, the handwashing and bathroom sinks in room X and neighboring room Y [control] and 1 hallway sink) and assessed the presence of VIM-CRPA. Moreover, 5 patients and 4 environmental VIM-CRPA underwent whole-genome sequencing (WGS). Results: From February to June 2020, of 21 patients admitted to room X, 9 (43%) underwent discharge screening and 4 (44%) were colonized with VIM-CRPA. Average room X length of stay was longer for colonized patients (11.3 vs 4.8 days). Drain swabs from room X’s bathroom and handwashing sinks grew VIM-CRPA; VIM-CRPA was not detected in tap water or other swab samples. VIM-CRPA from the environment and patients were sequence type 253 and varied by 0–13 single-nucleotide variants. ACH A replaced room X’s sinks and external plumbing in July. Discharge screening and contact precautions for all patients were discontinued in November, 5 months following the last case and 12 consecutive negative patient discharge screens. Improved sink hygiene and mechanism testing for CRPA from clinical cultures continued, with no new cases identified. Conclusions: An ICU room with a persistently contaminated sink drain was a persistent reservoir of VIM-CRPA. The room X attack rate was high, with VIM-CRPA acquisition occurring in >40% of patients screened. The use of contaminated plumbing fixtures in ACH have the potential to facilitate transmission to patients but may be challenging to identify and remediate. All healthcare facilities should follow sink hygiene best practices. Funding: No Disclosures: None Cambridge University Press 2021-07-29 /pmc/articles/PMC9551474/ http://dx.doi.org/10.1017/ash.2021.47 Text en © The Society for Healthcare Epidemiology of America 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Outbreaks
Chan, Allison
Shugart, Alicia
Burks, Albert
Moore, Christina
Gable, Paige
Moulton-Meissner, Heather
McAllister, Gillian
Halpin, Alison
Walters, Maroya
Keaton, Amelia
Tobey, Kelley
Thure, Katie
Schmedes, Sarah
Gable, Paige
Hardin, Henrietta
Lawsin, Adrian
Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title_full Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title_fullStr Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title_full_unstemmed Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title_short Verona Integron-Encoded Metallo-Beta-Lactamase (VIM)–Producing Pseudomonas aeruginosa Outbreak Associated with Acute Care
title_sort verona integron-encoded metallo-beta-lactamase (vim)–producing pseudomonas aeruginosa outbreak associated with acute care
topic Outbreaks
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551474/
http://dx.doi.org/10.1017/ash.2021.47
work_keys_str_mv AT chanallison veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT shugartalicia veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT burksalbert veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT moorechristina veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT gablepaige veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT moultonmeissnerheather veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT mcallistergillian veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT halpinalison veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT waltersmaroya veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT keatonamelia veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT tobeykelley veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT thurekatie veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT schmedessarah veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT gablepaige veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT hardinhenrietta veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare
AT lawsinadrian veronaintegronencodedmetallobetalactamasevimproducingpseudomonasaeruginosaoutbreakassociatedwithacutecare